Delaware Intellectual Property Cases
Cases 161 - 170 of 1,223
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2023cv01015
Plaintiff:
Heron Therapeutics, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
United Therapeutics Corporation v. Liquidia Technologies, Inc.
as 1:2023cv00975
Plaintiff:
United Therapeutics Corporation
Defendant:
Liquidia Technologies, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Bionpharma Inc.
as 1:2023mc00396
Plaintiff:
Azurity Pharmaceuticals, Inc.
Defendant:
Bionpharma Inc.
Petitioner:
QHP Capital GP, LLP
Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al
as 1:2023cv00964
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Zenara Pharma Private Limited
as 1:2023cv00924
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Zenara Pharma Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv00923
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Cipla Limited
as 1:2023cv00909
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Zenara Pharma Private Limited et al
as 1:2023cv00892
Plaintiff:
AbbVie Inc.
Defendant:
Zenara Pharma Private Limited and Biophore India Pharmaceuticals Private Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
